Holen Sie sich die Stockscreener-App
28.35
3.58%
0.98
Handel nachbörslich:
28.35
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Options exercised over three months will supply an officer's planned sale at Adaptive Biotechnologies (ADPT). - Stock Titan
Adaptive Biotechnologies slips as recent rally cools despite no clear new negative catalyst - Quiver Quantitative
ADPT Maintained by Guggenheim -- Price Target Raised to $32 - GuruFocus
ETFs Investing in Adaptive Biotechnologies Corp. Stocks - TradingView
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rated "Buy" in New Coverage at The Goldman Sachs Group - MarketBeat
ADPT Initiates Coverage On Goldman Sachs -- Rating Set to Buy - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Stock Down 3.1% but Still O - GuruFocus
Form 4 Adaptive Biotechnologies Corp For: 28 September By Investing.com - Investing.com South Africa
Adaptive Biotechnologies CPO Francis Lo sells $3.2 million in stock - Investing.com
Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure - Yahoo Finance
Adaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now? - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Stock Up 6.0% but GF Value Says Overvalued -- GF Score: 68/100 - GuruFocus
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 4.4%Should You Buy? - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at 28.79 USD - Investing.com
Adaptive Biotechnologies stock hits 52-week high at 28.79 USD By Investing.com - Investing.com Australia
NCCN’s Myeloma MRD Update Spotlighting clonoSEQ Could Be A Game Changer For Adaptive Biotechnologies (ADPT) - Yahoo Finance
Adaptive Biotechnologies (ADPT) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Adaptive Biotechnologies (ADPT): Can Blood Cancer Guidelines Boost Repeat Testing? - Insider Monkey
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year HighShould You Buy? - MarketBeat
Bank of America Corp DE Makes New Investment in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Tidal Investments LLC Takes $855,000 Position in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies CPO Francis Lo sells $3.2m in stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies CPO Francis Lo sells $3.2m in stock - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 115,406 Shares - MarketBeat
Adaptive Biotechnologies (ADPT) HR chief sells over 100,000 shares under preset plan - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Key Financial Ratios – Valuation, Profitability & More - Value Research
Adaptive biotechnologies chief commercial officer sells $32,265 in shares. - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 1,195 Shares - MarketBeat
Adaptive Biotechnologies (NASDAQ: ADPT) CCO sells shares under pre-set trading plan - Stock Titan
ADPT Looks 137.6% Overvalued on GF Value™ - GuruFocus
Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ® - Yahoo Finance
Alert incorrectly tagged to Adaptive Biotechnologies withdrawn - marketscreener.com
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Adaptive Biotechnologies (ADPT) officer to sell 142K shares - Stock Titan
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 52-Week HighTime to Buy? - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at 26.89 USD By Investing.com - Investing.com India
A Look at Adaptive Biotechnologies Corp (ADPT) After 7.7% Gain -- GF Value $11.66 vs Price $26.68 - GuruFocus
Officer at Adaptive Biotechnologies (NASDAQ: ADPT) plans sale of 1,195 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 6.4%What's Next? - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at 26.89 USD - Investing.com
Adaptive Biotechnologies Corp (ADPT) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Legal & General Group Plc Takes $7.62 Million Position in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies (NASDAQ: ADPT) director reports stock gift, still holds 66,100 shares - Stock Titan
Wellington Management Group LLP Has $126.80 Million Stake in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - The Manila Times
Morgan Stanley’s healthcare conference sets a biotech chat for Sept. 15 - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Peer Comparison – Compare with Others - Value Research
Adaptive Biotechnologies Corp (ADPT) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Director Katey Owen Sells 9,615 Shares of Adaptive Biotechnologies Corp (ADPT) - GuruFocus
Adaptive Biotechnologies director Owen sells $249,990 in stock. By Investing.com - Investing.com India
Adaptive Biotechnologies director Owen sells $249,990 in stock. - Investing.com
Adaptive Biotechnologies stock hits 52-week high at $26.63 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at $26.63 - Investing.com
Adaptive Biotech (NASDAQ: ADPT) director lines up $249,990 stock sale - Stock Titan
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - inkl
0.97%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):